Grants and Contributions:
Title:
Identification of a Lead Compound for the Treatment of Rheumatoid Arthritis (RA)
Agreement Number:
872369
Agreement Value:
$49,999.00
Agreement Date:
Sep 1, 2016 - Sep 30, 2019
Description:
The main objective of this project is to identify a lead biological candidate for the treatment of Rheumatoid Arthritis (RA).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5T 4T5
Reference Number:
172-2018-2019-Q1-872369
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
829919521
Recipient Type:
For-profit organization
Additional Information:
The end date of this agreement has been modified by 213 days.
Amendment Date
May 22, 2018
Recipient's Operating Name:
Augurex
Recipient's Legal Name:
Augurex Life Sciences Corp.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: